Literature DB >> 857375

Nonpapillary carcinoma in situ and atypical hyperplasia in cancerous bladders: further studies of surgically removed bladders by mapping.

L G Koss, I Nakanishi, S Z Freed.   

Abstract

Complete mapping of epithelium has been performed in 10 bladders surigcally removed for cancer. In all cases, in areas adjacent to or distant from the visible tumors, nonpapillary carcinoma in situ and related lesions such as atypical hyperplasia could be demonstrated. More importantly, in 5 of the 10 bladders, areas of occult invasive carcinoma derived from such abnormal epithelia have been recorded. These findings fully confirm prior observations and raise the number of totally mapped bladders to 20. The histologic findings in the entire series of 20 cases are discussed and the distribution of cancer and precancerous lesions tabulated. It is suggested that the areas of the bladder most frequently affected by precancerous lesions are the left and right lateral walls and the posterior wall. The trigone and the dome are less frequently involved. The need for aggressive assessment of bladder epithelium in patients with tumors of the bladder and/or early radical treatment for patients with non papillary carcinoma in situ is discussed in light of these observations.

Entities:  

Mesh:

Year:  1977        PMID: 857375     DOI: 10.1016/0090-4295(77)90227-8

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  6 in total

Review 1.  Current approaches in the treatment of bladder cancer and policy in Marmara University Hospital.

Authors:  D Ersev; Y Ilker; F Simşek; A Akdaş
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

Review 2.  Therapy of bladder cancer.

Authors:  K H Bichler; S Halim
Journal:  Int Urol Nephrol       Date:  1987       Impact factor: 2.370

3.  Understanding the development of human bladder cancer by using a whole-organ genomic mapping strategy.

Authors:  Tadeusz Majewski; Sangkyou Lee; Joon Jeong; Dong-Sup Yoon; Andrzej Kram; Mi-Sook Kim; Tomasz Tuziak; Jolanta Bondaruk; Sooyong Lee; Weon-Seo Park; Kuang S Tang; Woonbok Chung; Lanlan Shen; Saira S Ahmed; Dennis A Johnston; H Barton Grossman; Colin P Dinney; Jain-Hua Zhou; R Alan Harris; Carrie Snyder; Slawomir Filipek; Steven A Narod; Patrice Watson; Henry T Lynch; Adi Gazdar; Menashe Bar-Eli; Xifeng F Wu; David J McConkey; Keith Baggerly; Jean-Pierre Issa; William F Benedict; Steven E Scherer; Bogdan Czerniak
Journal:  Lab Invest       Date:  2008-05-05       Impact factor: 5.662

4.  Stem cell marker-positive stellate cells and mast cells are reduced in benign-appearing bladder tissue in patients with urothelial carcinoma.

Authors:  Björn L Isfoss; Christer Busch; Helena Hermelin; Anette T Vermedal; Marianne Kile; Geir J Braathen; Bernard Majak; Aasmund Berner
Journal:  Virchows Arch       Date:  2014-02-26       Impact factor: 4.064

5.  Proliferative activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors.

Authors:  C Limas; R Bair; P Bernhart; P Reddy
Journal:  J Clin Pathol       Date:  1993-09       Impact factor: 3.411

6.  An improved mouse orthotopic bladder cancer model exhibiting progression and treatment response characteristics of human recurrent bladder cancer.

Authors:  Tomoharu Naito; Tamami Higuchi; Yasuhiro Shimada; Chihaya Kakinuma
Journal:  Oncol Lett       Date:  2019-12-02       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.